Business Context and Reporting Period
Company: ASTROTECH Corp (Delaware)
Filing Type: Form 8-K (Current Report)
Date of Report: March 27, 2020
Event: Entry into a Material Definitive Agreement for a registered direct offering of common stock.
Key Financial Metrics
This filing reports on a capital raise event rather than periodic operating results. Specific metrics include:
- Shares Issued: 873,335 shares of Common Stock.
- Offering Price: $3.75 per share.
- Gross Proceeds: Approximately $3.275 million.
- Placement Agent Fees: 7.0% cash fee plus a 1.0% management fee ($32,750).
- Other Expenses: $50,000 non-accountable expense allowance and $12,900 in clearing expenses.
- Warrants Issued: 61,133 warrants (7.0% of shares sold) with an exercise price of $4.6875 per share.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transactional report.
Material Changes
The primary material change is the execution of a Securities Purchase Agreement to raise capital. The company agreed to issue new shares, which will increase the outstanding share count upon closing. The filing does not provide comparative financial data against a prior period.
Guidance, Outlook, and Risks
- Closing Date: Expected on or about March 30, 2020, subject to customary conditions.
- Covenants: The agreement includes a prohibition on the Company conducting certain variable rate transactions for one year from the closing date, subject to exceptions.
- Unregistered Securities: Placement Agent Warrants were issued in reliance on Section 4(a)(2) of the Securities Act and are not registered.
- Management Commentary: The filing incorporates a press release (Exhibit 99.1) regarding the pricing of the offering but does not contain detailed management discussion or outlook within the text provided.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds after deducting all fees and expenses.
- Confirm the exact number of shares outstanding post-offering to assess dilution impact.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and termination rights.
- Check the exercise terms and vesting schedule of the Placement Agent Warrants (Exhibit 4.1).
- Monitor the company's use of proceeds as disclosed in the press release (Exhibit 99.1).